Living with Reflex Sympathetic Dystrophy can make ordinary tasks feel impossible
A shower can hurt. A bedsheet touching your skin can feel unbearable. Walking across a room may trigger swelling, burning pain, or a sudden flare that lasts for hours.
RSD is the older name for Complex Regional Pain Syndrome Type 1, commonly called CRPS-1. The name changed, but the daily reality did not.
There is no single strategy that works for every person. The strongest approach usually combines careful medical assessment, controlled rehabilitation, symptom management, and treatment matched to the stage of the disease.
Here is how to deal with RSD without depending on vague advice or chasing one temporary pain fix after another.
What to do during an RSD flare-up
When pain suddenly increases, the natural response is to stop moving the affected limb completely.
That may help for a short period, but extended immobilisation can increase stiffness, weakness, fear of movement, and loss of function.
During a flare:
-
Reduce the intensity of activity without abandoning movement completely.
-
Use slow, controlled movements within the limits given by your medical or rehabilitation team.
-
Remove tight clothing, footwear, jewellery, or compression that aggravates swelling.
-
Track changes in skin colour, temperature, swelling, movement, and pain.
-
Use prescribed medication exactly as directed.
-
Contact your clinician if the flare is unusually severe, follows a new injury, or includes symptoms that are not typical for you.
Do not assume every new symptom is automatically CRPS. Infection, vascular problems, nerve compression, fractures, and other conditions can produce overlapping symptoms. New or rapidly changing symptoms need medical assessment.
Build a daily routine around function, not pain alone
Pain scores matter, but they are not the only measure of progress.
Ask better questions:
- Can you tolerate touch for longer?
- Is the swelling changing?
- Can you move the joint further?
- Are you using the affected hand or foot more naturally?
- Can you stand, walk, dress, or sleep with less difficulty?
These changes may appear before a dramatic fall in pain. A practical daily plan may include:
Gentle movement
Use short, frequent sessions instead of one aggressive workout. The goal is controlled exposure, not forcing the limb through severe pain.
Desensitisation
A therapist may introduce different textures, temperatures, or light contact to help the nervous system tolerate normal sensation again. This should be progressive and individualised.
Graded motor imagery
This can include left-right recognition, imagined movement, and mirror therapy. The aim is to retrain how the brain represents and protects the affected limb.
Sleep protection
Poor sleep can increase pain sensitivity and make rehabilitation harder. Keep a consistent sleep schedule and discuss persistent sleep problems with your clinician.
Flare tracking
Record activity, sleep, swelling, medication, temperature changes, and pain. Patterns are more useful than isolated bad days.
Physical rehabilitation remains a central part of CRPS management because preserving movement and function can help limit secondary changes caused by disuse and persistent pain.
How the main RSD treatments compare
RSD treatment is not a competition between one drug and another. Different treatments target different parts of the problem.
Physical and occupational therapy
Physical and occupational therapy aim to restore movement, strength, coordination, and confidence in using the affected limb.
This is not simply exercise. A good CRPS rehabilitation plan may include desensitisation, graded movement, functional training, mirror therapy, and strategies for returning to daily activities.
Therapy that is too aggressive can trigger a flare. Therapy that is too cautious can leave the limb progressively weaker. The plan needs to be paced properly.
Ketamine infusions
Ketamine acts on NMDA receptors involved in pain signalling and central sensitisation. Some patients report meaningful pain relief, particularly when other treatments have failed.
The problem is durability.
A 2026 systematic review found that intravenous ketamine may reduce pain in the short term, but response varies and limited longer-term data suggest that the effect can weaken over time. Ketamine can also cause nausea, dizziness, sedation, perceptual changes, and cardiovascular effects, so medical monitoring is required.
Ketamine may reduce pain. It does not automatically restore movement or reverse every process involved in CRPS.
Sympathetic nerve blocks
A sympathetic block involves injecting local anaesthetic near sympathetic nerves. Stellate ganglion blocks may be used for an upper limb, while lumbar sympathetic blocks may be considered for a lower limb.
Some patients experience a temporary window of pain relief that helps them participate in rehabilitation. Others receive little or no benefit.
Research remains mixed. An overview of systematic reviews found no high-certainty evidence for CRPS interventions and reported that local anaesthetic sympathetic blockade probably does not reduce pain compared with placebo in the evidence assessed.
A block should not be sold as a guaranteed reset. Its value depends on patient selection, the treatment goal, and what the patient does with any temporary improvement.
Neridronate infusions
Neridronate is a bisphosphonate. Unlike a fast-acting painkiller, it interacts with abnormal bone turnover and inflammatory processes believed to be involved in some forms of early CRPS-1.
An Italian randomised, double-blind, placebo-controlled study enrolled 82 people with CRPS-1 affecting a hand or foot. Participants received four 100 mg intravenous infusions over ten days. The Neridronate group showed greater improvements in pain and other clinical measures than the placebo group.
That result matters, but it does not prove that every CRPS patient will respond.
The Italian product information for Nerixia lists symptomatic treatment of algodystrophy in adults whose symptoms began less than four months earlier. This makes timing, diagnosis, disease stage, kidney function, calcium status, and medical history important parts of screening.
Neridronate is authorised in Italy for this indication. It is not approved specifically for CRPS by the United States Food and Drug Administration.
Is Neridronate a cure for RSD?
Calling any treatment a guaranteed cure is bad medicine.
Italian studies have reported clinically relevant and persistent benefits in selected patients with acute CRPS-1. Longer-term observational research has also reported improvements after treatment.
Those findings are promising. They still do not guarantee remission for every patient, and Neridronate should not be presented as a replacement for rehabilitation.
The more honest question is:
Are you medically eligible, and does the evidence fit your specific form and stage of CRPS?
That answer requires more than a social media message. It requires a review of your diagnosis, symptom duration, affected region, medical records, current medication, kidney health, calcium levels, and other possible contraindications.
When should you consider treatment in Rome?
Travelling for treatment is a serious decision. It may make sense when:
-
Your diagnosis of CRPS-1 has been properly established.
-
Your treating doctors have discussed the risks and alternatives.
-
Neridronate is not accessible in your country.
-
You understand that eligibility is not automatic.
-
You can continue rehabilitation after returning home.
-
You have compared the complete cost, not just the price of the medication.
Do not compare only the cost of one infusion.
Include medical consultations, diagnostic tests, treatment fees, flights, accommodation, local transport, travel insurance, and follow-up care. Rome may be a more practical option than repeated procedures in some countries, but that needs to be confirmed using real written quotes.
What CRPS Neridronate Rome can assist with
CRPS Neridronate Rome helps international patients understand the Italian treatment pathway.
Assistance may include:
-
Reviewing available medical information before travel
-
Coordinating an eligibility assessment with the Italian medical team
-
Explaining the treatment schedule
-
Helping patients prepare the required documents and tests
-
Providing practical guidance for travelling to Rome
-
Supporting communication before and after treatment
CRPS Neridronate Rome does not replace your treating physician and cannot guarantee a clinical outcome.
The goal is simpler: help you find out whether the Italian Neridronate pathway is medically appropriate before you spend money or make unnecessary travel plans.
Take the next step
You do not need another miracle claim.
You need a clear answer about whether Neridronate fits your diagnosis, disease stage, and medical history.
Contact CRPS Neridronate Rome to request an initial consultation. The team can explain the process, review the information required for medical screening, and help you understand what treatment in Rome would involve.
Book your consultation with CRPS Neridronate Rome and find out whether you may be eligible for the Italian Neridronate treatment pathway.
Medical disclaimer
This article provides general educational information. It is not medical advice, diagnosis, or a treatment recommendation. CRPS requires individual assessment by qualified healthcare professionals. Never stop medication, begin treatment, or travel for a medical procedure without appropriate clinical advice.